Vallon Pharmaceuticals (VLON) Filings

DEFA14A

VLON Vallon Pharmaceuticals Inc

30 Mar 23

Additional proxy soliciting materials

4:09pm

DEFA14A

VLON Vallon Pharmaceuticals Inc

23 Mar 23

Additional proxy soliciting materials

4:04pm

EFFECT

VLON Vallon Pharmaceuticals Inc

9 Mar 23

Notice of effectiveness

12:15am

424B3

VLON Vallon Pharmaceuticals Inc

8 Mar 23

Prospectus supplement

4:18pm

8-K

VLON Vallon Pharmaceuticals Inc

2 Mar 23

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

4:07pm

8-K

VLON Vallon Pharmaceuticals Inc

24 Feb 23

Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial Results

7:34am

SC 13G/A

VLON Vallon Pharmaceuticals Inc

13 Feb 23

Vallon Pharmaceuticals / Lind Global Fund II ownership change

4:30pm

SC 13G/A

Bigger Capital Fund L P

30 Jan 23

Vallon Pharmaceuticals / BIGGER CAPITAL FUND L P ownership change

9:09am

S-4/A

VLON Vallon Pharmaceuticals Inc

27 Jan 23

Registration of securities issued in business combination transactions (amended)

6:02pm

425

VLON Vallon Pharmaceuticals Inc

11 Jan 23

Business combination disclosure

8:30am

8-K

VLON Vallon Pharmaceuticals Inc

11 Jan 23

Vallon Pharmaceuticals and GRI Bio to Present at the Virtual Investor 2023 Companies to Watch Event

8:30am

8-K

VLON Vallon Pharmaceuticals Inc

29 Dec 22

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

4:06pm

SC 13G/A

Markey John

27 Dec 22

Vallon Pharmaceuticals / Markey John ownership change

11:09am

S-4

VLON Vallon Pharmaceuticals Inc

23 Dec 22

Registration of securities issued in business combination transactions

6:06am

4

Marella Thorell

15 Dec 22

Vallon Pharmaceuticals / Marella Thorell ownership change

4:26pm

8-K

VLON Vallon Pharmaceuticals Inc

13 Dec 22

Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators

4:09pm